MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain
MIAMI, FL / ACCESS Newswire / March 13, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on ...
CNN on MSN7d
Common vaginal condition is really an STD, study finds
Bacterial vaginosis, which affects nearly 1 in 3 women, should be considered a sexually transmitted disease, according to a ...
Business Insider8d
The 5 best flea treatments for cats in 2025
Revolution Plus is my best overall pick for a prescription topical flea and tick treatment for cats. It also controls heartworms, roundworms, hookworms, ear mites, and tapeworms. If you're looking ...
Berkman Klein Center15d
Berkman Klein Announces Spring Speaker Series
The Berkman Klein Center for Internet & Society is thrilled to announce the Spring Speaker Series! Building on the success of ...
Hosted on MSN1mon
Woman’s Courageous Battle with Topical Steroid Withdrawal
Watch this brave woman share her ongoing journey with the skin condition Topical Steroid Withdrawal. Josie North, a card game designer, from Shropshire, UK, first experienced signs of Topical ...
CNN4y
Dare Bioscience, Inc.
Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego ...
Mira Pharmaceuticals expands Ketamir-2 development with topical treatment
MIRA Pharmaceuticals (MIRA) announced the formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain.